Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219186 · ClinicalTrials.gov registry record · Early Phase 1
Kava Aging and Mobility Study
A Early Phase 1 study, sponsored by University of Florida.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
NCT07219186 is a Early Phase 1 study that has not yet begun recruiting, run by University of Florida. The registered enrollment target is 40 participants.
The verdict
NCT07219186, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Florida.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if AB-free kava works to improve mobility and physical function in older adults with sleep difficulties. It will also learn about the safety of AB-free kava. The main questions it aims to answer are: * Does AB-free kava improve physical function and/or mobility? * Does AB-free kava effect sleep, stress, or cellular signaling? Researchers will compare AB-free kava to a placebo (a look-alike substance that contains no drug) to see if AB-free kava works to improve mobility and physical functioning.
Interventions
- OTHER Placebo
- DRUG AB-free kava
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07219186
The ClinicalTrials.gov registry entry for NCT07219186 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07219186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07219186 about?
NCT07219186 is a clinical study titled "Kava Aging and Mobility Study". The goal of this clinical trial is to learn if AB-free kava works to improve mobility and physical function in older adults with sleep difficulties. It will also learn about the safety of AB-free kava. The main questions it aims to answer are: * Does AB-free kava improve physical function and/or mo...
What is the current status of trial NCT07219186?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2026-04. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07219186?
The interventions under investigation include: Placebo (OTHER), AB-free kava (DRUG).
Who is sponsoring clinical trial NCT07219186?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.